Cynapsus Therapeutics Inc. (TSXV: CTH) Interview with Andra Enescu

Anthony Giovinazzo, president & CEO of Cynapsus Therapeutics Inc. (TSXV: CTH) interviewed by Andra Enescu. Cynapsus is a specialty clinical development pharmaceutical company targeting Parkinson’s Disease.